Join to view full profile
Regional Cancer Care Associates, LLC326 Professional View DriveFreehold, NJ 07728
Phone+1 732-431-8400
Fax+1 732-431-0114
Dr. Lamba is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gurpreet Lamba is an oncologist in Freehold and Toms River, NJ and is affiliated with multiple hospitals in the area, including Community Medical Center, CentraState Healthcare System, Hackensack Meridian Health Bayshore Community Hospital, Hackensack Meridian Health Jersey Shore University Medical Center, Hackensack Meridian Health Ocean Medical Center, Hackensack Meridian Health Riverview Medical Center, and Hackensack Meridian Health Raritan Bay Medical Center. He received his medical degree from Nehru Medical College R. Gandhi HS University and has been in practice 12 years. He also speaks multiple languages, including Hindi, Punjabi, and Urdu. He specializes in lymphoma and hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012- Westchester Medical CenterResidency, Internal Medicine, 2006 - 2009
Nehru Medical College/ R. Gandhi HS UniversityClass of 2005
Certifications & Licensure
NJ State Medical License 2014 - 2027
NY State Medical License 2020 - 2027
VT State Medical License 2012 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2016-2017
Clinical Trials
- Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Dec 14
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
Publications & Presentations
PubMed
- 4 citationsDelayed Diagnosis of Cardiac Amyloidosis Secondary to Multiple MyelomaAhmad Qatanani, Shereen Dahab, Steven Douedi, Yumna Hamid, Sameh Girgis
Journal of Medical Cases. 2021-09-29 - 3 citationsAcute kidney injury secondary to thrombotic microangiopathy associated with idiopathic hypereosinophilic syndrome: a case report and review of the literatureDiana Curras-Martin, Swapnil Patel, Huzaif Qaisar, Sushil K. Mehandru, Avais Masud
Journal of Medical Case Reports. 2019-09-05 - 12 citationsCharacterization of purine‐rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognosticationRobert J. Kelm, Gurpreet Lamba, Jamie E. Levis, Chris E. Holmes
Journal of Cellular Biochemistry. 2018-02-01
Professional Memberships
- Member
Other Languages
- Hindi, Punjabi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
